A curated collection of prestigious non-dilutive funding opportunities specifically designed to support women entrepreneurs in the life sciences sector. This list highlights grants that accelerate research, bridge the funding gap, and provide capital for early-stage biotechnology ventures without requiring equity.
Get targeted exposure with custom position pinning and highlighted placement.
The National Institutes of Health offers competitive grants for small business ventures conducting research with potential commercial applications. These funds support early-stage biological and biomedical research, providing critical capital to women-led startups developing novel therapeutics or diagnostics.
Designed for women and LGBTQ+ founders, this grant provides $25,000 to $75,000 to support life science innovation. It specifically targets early-stage companies to help cover initial research costs and product development expenses in the biotechnology sector.
This accelerator and grant program provides $500,000 in non-dilutive capital to women-led climate and health technology startups. It includes access to a network of experts and mentorship, helping biotech founders refine their business models and scientific approaches.
A high-risk, high-reward grant mechanism that supports unconventional research approaches in any NIH area. Women-led teams proposing groundbreaking biotechnological methods or interdisciplinary solutions can access substantial funding to pursue innovative scientific questions.
BIO offers various fellowship and grant programs aimed at supporting the next generation of life science innovators. These opportunities often focus on diversity and inclusion, providing financial support and professional development for women leading biotech ventures.
Supports research and projects that address women's health issues through innovative biomedical solutions. This grant provides funding for startups developing new treatments, prevention strategies, or diagnostic tools specifically targeting conditions unique to or prevalent in women.
Provides funding for startups to test their business concepts and go-to-market strategies within the broader science and engineering community. Women-led biotech teams can use this to validate their commercial viability alongside scientific rigor, essential for attracting further investment.
Provides international recognition and substantial financial prizes to outstanding women scientists. While often research-focused, these awards can provide significant capital and prestige for entrepreneurs in biotechnology who are transitioning from academic research to commercial applications.
Although broader in scope, this venture fund and accelerator often includes early-stage biotech and healthcare startups. It offers non-dilutive funding combined with intensive mentorship, helping women founders navigate the complex regulatory landscape of the biotech industry.
Requires collaboration between small businesses and research institutions, ideal for academic spinouts led by women. This program provides substantial funding for R&D, ensuring that scientific breakthroughs in biotechnology are effectively translated into marketable products.
Supports researchers at the beginning of their careers to pursue ambitious projects. Women-led biotech startups with strong scientific foundations can leverage these grants to fund initial discovery phases, building a robust portfolio for future commercialization.
While primarily technical, Amazon offers significant cloud credits and research grants that reduce operational costs for biotech startups. This indirect financial support allows women-led companies to allocate more resources to core research and development activities.
Funds high-risk, high-reward research in biological technologies. Women-led startups proposing innovative solutions for national security-related biological challenges can access substantial federal funding through specific solicitation programs managed by DARPA.
Provides institutional support to increase the participation of underrepresented groups in the biomedical workforce. Women-led entities can benefit from the infrastructure and networking opportunities that enhance the capacity to secure and manage large-scale grants.
A corporate venture capital arm that invests in external biotech innovations. While equity-based, they often partner with non-dilutive grant recipients or provide strategic partnerships that validate the startup's technology, making it more attractive to pure grant funders.
Offers grant funding for research focused on blood cancers. Women-led biotech startups developing novel therapies or diagnostic tools for hematological malignancies can apply for competitive grants that support early-stage clinical or preclinical development.
Supports innovative research into the causes, prevention, and treatments of Alzheimer's disease. Women-led biotech ventures proposing novel approaches to neurodegenerative diseases can secure funding that bridges the gap between academic discovery and commercial product.
Targets outstanding investigators with innovative ideas who lack the typical track record for larger grants. Women-led biotech founders with novel, high-impact scientific concepts can receive substantial, flexible funding to pursue unconventional research paths.
Often associated with the annual convention, these grants or subsidized access programs support emerging companies. Women-led startups can gain exposure, networking opportunities, and potential non-dilutive funding connections within the global biotech community.
Provides significant funding for investigators conducting cancer research. Women-led biotech companies focusing on oncology therapeutics or diagnostics can leverage these awards to fund pivotal research stages, demonstrating proof of concept to future investors.